All the latest UK technology news, reviews and analysis
|
|
|
23 Mar 2009
Oracle has announced plans to acquire Relsys, a firm that provides drug safety and risk management solutions to the health sciences industry.
Terms of the deal have not been disclosed, but Oracle said that it will add Relsys to its Health Sciences global business unit.
The database vendor claimed in a report that the combination of expertise will deliver the "only suite of software applications that supports end-to-end drug safety processes across clinical development, post-market surveillance and patient care".
"The health sciences industry is increasing investments in software that provides greater transparency into drug safety, and helps improve the overall safety of therapies," said Neil de Crescenzo, Oracle Health Sciences senior vice president and general manager.
"With the addition of Relsys, Oracle is uniquely positioned to help our customers improve drug safety by delivering a comprehensive software solution that enables our vision of integrated safety and risk management supported by advanced analytics."
Latest stories from Finance
Related articles
Related jobs
Poll
What is the most important IT priority for your company this year?
Hands on with the highly anticipated Android 4.0 Ice Cream Sandwich hybrid tablet
Connect with V3.co.uk
This paper focuses on a series of best practices and techniques for development teams looking to improve their software development processes
Why good data management at all levels is essential in the modern business (video, 6mins)
Desktop Support Manager 3 month contract - to start...
/ Programme Manager / 45k / Significant benefits / London...
Automation Test Manager Selenium London 75k Automation...
Mitel 3300 Engineer Key skills Mitel 3300...
Keep up to date with the latest products, services and technologies from the world's leading IT companies. IThound.com brings you over 2,000 white papers, case studies and analyst reports.
Do you agree?